On the recordFebruary 7, 2024
Speed of access getting drugs to market, but then you are actively working to block the less expensive biosimilars and generics to come to market, and that is something we should address.
Source
congress.govSpeed of access getting drugs to market, but then you are actively working to block the less expensive biosimilars and generics to come to market, and that is something we should address.
Highlighting the contradiction in drug companies' actions regarding market access.
Share
More from Maggie Hassan
On time delivery for first-class mail in the New Hampshire region has fallen by more than 10 percentage points over the last eight years and is now more than five percentage points below the postal service's own target of 87%.
During a cost-of-living emergency for families and small businesses, Senate Republicans today — over bipartisan opposition — pushed through legislation that puts the interests of the President over the pocketbooks of the American people.
No one should be denied a life-saving organ transplant just because they have a disability.